Inovio Pharmaceuticals
INO
#8327
Rank
โ‚ฌ0.27 B
Marketcap
1,48ย โ‚ฌ
Share price
16.43%
Change (1 day)
-13.11%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,56ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,67ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,65ย โ‚ฌ an increase over its 2024 EPS that were of -3,60ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,56ย โ‚ฌ-5.22%
2025-1,65ย โ‚ฌ-54.18%
2024-3,60ย โ‚ฌ-35.14%
2023-5,55ย โ‚ฌ-56.62%
2022-12,78ย โ‚ฌ-19.54%
2021-15,89ย โ‚ฌ35.9%
2020-11,69ย โ‚ฌ-11.57%
2019-13,22ย โ‚ฌ15.24%
2018-11,47ย โ‚ฌ-2.78%
2017-11,80ย โ‚ฌ6.93%
2016-11,04ย โ‚ฌ134.88%
2015-4,70ย โ‚ฌ-29.51%
2014-6,67ย โ‚ฌ-57.34%
2013-15,63ย โ‚ฌ146.55%
2012-6,34ย โ‚ฌ20.83%
2011-5,25ย โ‚ฌ-29.41%
2010-7,43ย โ‚ฌ-48.48%
2009-14,42ย โ‚ฌ10%
2008-13,11ย โ‚ฌ11.11%
2007-11,80ย โ‚ฌ-41.3%
2006-20,11ย โ‚ฌ-66.91%
2005-60,76ย โ‚ฌ110.61%
2004-28,85ย โ‚ฌ-61.63%
2003-75,18ย โ‚ฌ186.67%
2002-26,23ย โ‚ฌ
2001N/A-100%
2000-20,98ย โ‚ฌ-60.71%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
6,08ย โ‚ฌ-465.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,78ย โ‚ฌ-386.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,65ย โ‚ฌ-138.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,82ย โ‚ฌ 69.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
0,90ย โ‚ฌ-154.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-257.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-3,03ย โ‚ฌ 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA